Percutaneous transluminal angioplasty in severe diabetic foot ischemia: outcomes and prognostic factors

被引:28
|
作者
Jacqueminet, S [1 ]
Hartemann-Heurtier, A
Izzillo, R
Cluzel, P
Golmard, JL
Van, GH
Koskas, F
Grimaldi, A
机构
[1] Hop La Pitie Salpetriere, Diabet & Metab Dis Unit, Serv Diabetol & Metab, F-75651 Paris, France
[2] Hop La Pitie Salpetriere, Dept Radiol Intervent, F-75651 Paris, France
[3] Univ Paris 06, Serv Biostat, Paris, France
[4] Hop La Pitie Salpetriere, Dept Chirurg Vasc, F-75651 Paris, France
关键词
diabetic foot ulcer; peripheral arterial disease; percutaneous transluminal angioplasty;
D O I
10.1016/S1262-3636(07)70206-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To evaluate the outcomes of severe ischemic diabetic foot ulcers for which percutaneous transluminal angioplasty (PTA) was considered as the first-line vascular procedure. Factors associated with successful PTA were sought. Research design and methods: In 32 consecutive diabetic patients with foot ulcers and severe limb ischemia, PTA was performed if feasible; if not, primary bypass grafting was done when feasible. All patients were followed until healing or for at least one year. Patients with worsening ulcers after PTA underwent bypass grafting. Clinical and angiographic factors influencing outcomes after PTA were sought by univariate and multivariate analysis. Results: PTA was done in 25 of the 32 (78%) patients, and considered clinically successful in 13 (52%). After 1 year, the healing rate was 70% and the limb salvage rate 90%. Successful PTA was significantly associated with a higher post-PTA transcutaneous oxygen pressure (P = 0.03) and presence of at least one patent pedal vessel (P = 0.03) in the univariate analysis; only a patent pedal vessel was significant in the multivariate analysis. Conclusion: Primary PTA in diabetic patients with severe ischemic foot ulcers provides similar outcomes to usual results obtained in severe ischemia in absence of diabetes. The presence of one patent pedal vessel on arteriography before PTA is the best prognostic factor.
引用
收藏
页码:370 / 375
页数:6
相关论文
共 50 条
  • [21] Difference in Serum Endostatin Levels in Diabetic Patients with Critical Limb Ischemia Treated by Autologous Cell Therapy or Percutaneous Transluminal Angioplasty
    Nemcova, Andrea
    Jirkovska, Alexandra
    Dubsky, Michal
    Kolesar, Libor
    Bem, Robert
    Fejfarova, Vladimira
    Pysna, Anna
    Woskova, Veronika
    Skibova, Jelena
    Jude, Edward B.
    CELL TRANSPLANTATION, 2018, 27 (09) : 1368 - 1374
  • [22] Monitoring of Foot Oxygenation with Near-infrared Spectroscopy in Patients with Critical Limb Ischemia Undergoing Percutaneous Transluminal Angioplasty: A Pilot Study
    Boezeman, R. P. E.
    Becx, B. P.
    van den Heuvel, D. A. F.
    Unlu, C.
    Vos, J. A.
    de Vries, J. P. P. M.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2016, 52 (05) : 650 - 656
  • [23] Evaluation of foot hypoperfusion and estimation of percutaneous transluminal angioplasty outcome in patients with critical limb ischemia using intravoxel incoherent motion microperfusion MRI
    Galanakis, Nikolaos
    Maris, Thomas G.
    Kalaitzakis, Georgios
    Kontopodis, Nikolaos
    Matthaiou, Nikolas
    Charalambous, Stavros
    Tsetis, Konstantinos
    Ioannou, Christos, V
    Karantanas, Apostolos
    Tsetis, Dimitrios
    BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1125)
  • [24] Factors affecting patency of arteriovenous fistula following first percutaneous transluminal angioplasty
    Yap, Yit-Sheung
    Chi, Wen-Che
    Lin, Cheng-Hao
    Liu, Yi-Chun
    Wu, Yi-Wen
    Yang, Hui-Yueh
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (01) : 80 - 86
  • [25] Factors affecting patency of arteriovenous fistula following first percutaneous transluminal angioplasty
    Yit-Sheung Yap
    Wen-Che Chi
    Cheng-Hao Lin
    Yi-Chun Liu
    Yi-Wen Wu
    Hui-Yueh Yang
    Clinical and Experimental Nephrology, 2021, 25 : 80 - 86
  • [26] Percutaneous transluminal angioplasty of crural arteries:: Diabetes and other factors influencing outcome
    Danielsson, G
    Albrechtsson, U
    Norgren, L
    Danielsson, P
    Ribbe, E
    Thörne, J
    Zdanowski, Z
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2001, 21 (05) : 432 - 436
  • [27] Prognostic factors for treatment of diabetic foot ulcers
    Coerper, S
    Flesch, I
    Becker, HD
    Koveker, G
    EFFICIENCY AND ECONOMICS OF CLINICAL CARE AND RESEARCH IN SURGERY, 1997, SUPPL : 566 - 568
  • [28] Percutaneous transluminal angioplasty improves glucose control and quality of life in patients with critical limb ischemia
    Tolva, V. S.
    Casana, R.
    Lonati, L.
    Invitti, C.
    Bertoni, G. B.
    Bianchi, P. G.
    Cireni, L. V.
    Parati, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 (15) : 2082 - 2087
  • [29] The role of dynamic contrast-enhanced MRI in evaluation of percutaneous transluminal angioplasty outcome in patients with critical limb ischemia
    Galanakis, Nikolaos
    Maris, Thomas G.
    Kontopodis, Nikolaos
    Ioannou, Christos, V
    Tsetis, Konstantinos
    Karantanas, Apostolos
    Tsetis, Dimitrios
    EUROPEAN JOURNAL OF RADIOLOGY, 2020, 129
  • [30] Influence of lipoprotein(a) on restenosis after femoropopliteal percutaneous transluminal angioplasty in Type 2 diabetic patients
    Maca, TH
    Ahmadi, R
    Derfler, K
    Ehringer, H
    Gschwandtner, ME
    Hörl, WH
    Katzenschlager, R
    Müller-Knespel, E
    Koppensteiner, R
    Schneidert, B
    Stümpflen, A
    Ugurluoglu, A
    Minar, E
    DIABETIC MEDICINE, 2002, 19 (04) : 300 - 306